1Hertweck C,Luzhetskyy A,Rebets Y. Type Ⅱpolyketide synthases:gaining a deeper insight into enzymatic teamwork[J].Natural Product Reports,2007,(01):162-190.doi:10.1039/b507395m.
2Fritzsche K,Ishida K,Hertweck C. Orchestration of discoid polyketide cyclization in the resistomycin pathway[J].Journal of the American Chemical Society,2008,(26):8307-8316.doi:10.1021/ja800251m.
3Chopra I,Roberts M. Tetracycline antibiotics:mode of action,applications,molecular biology,and epidemiology of bacterial resistancc[J].Microbiology and Molecular Biology Reviews,2001,(02):232-260.
4Binnie C,Warren M,Butler MJ. Cloning and heterologous expression in Streptomyces lividans of Streptomyces rimosus genes involved in oxytetracycline biosynthesis[J].Journal of Bacteriology,1989,(02):887-895.
5McCormick JR,Jensen ER. Biosynthesis of the tetracyclines.8.Characterization of 4-hydroxy-6-methylpretetramid[J].Journal of the American Chemical Society,1965.1794-1795.
6Rhodes PM,Hunter IS,Friend EJ. Recombinant DNA methods for the oxytetracycline producer Streptomyces rimosus[J].Biochemical Society Transactions,1984,(04):586-587.
7Zhang W,Watanabe K,Wang CC. Heterologous biosynthesis of amidated polyketides with novel cyclization regioselectivity from oxytetracycline polyketide synthase[J].Journal of Natural Products,2006,(11):1633-1636.doi:10.1021/np060290i.
8Majumdar S,Mukherjee S,Maiti A. Folic acid or combination of folic acid and vitamin B12 prevents shortterm arsenic trioxide-induced systemic and mitochondrial dysfinction and DNA damage[J].Environmental Toxicology,2009,(04):377-387.
9Stevens DC,Henry MR,Murphy KA. Heterologous expression of the oxytetracycline biosynthetic pathway in Myxococcus xanthus[J].Applied and Environmental Microbiology,2010,(08):2681-2683.
10Petkovi(c) H,Cullum J,Hranueli D. Genetics of Streptomyces rimosus,the oxytetracycline producer[J].Microbiology and Molecular Biology Reviews,2006,(03):704-728.doi:10.1128/MMBR.00004-06.
